dw a 2114r has been researched along with Cancer of Lung in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (16.67) | 18.7374 |
1990's | 5 (83.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ota, K | 1 |
Nakai, Y | 1 |
Inoue, S; Ito, M; Mizuno, S; Ohnuma, T | 1 |
Ariyoshi, Y; Fukuoka, M; Furusawa, M; Hasegawa, K; Kimura, I; Kumoi, T; Kurita, Y; Matsunaga, T; Niitani, H; Tamura, M | 1 |
Akamatsu, K; Endo, K; Koizumi, K; Koizumi, M; Matsumoto, T; Mitsui, H; Morikawa, K | 1 |
Hiraki, S; Kiura, K; Kozuka, A; Mima, Y; Moritaka, T; Ohnoshi, T; Ueoka, H; Uji, H; Yamashita, H; Yonei, T | 1 |
2 review(s) available for dw a 2114r and Cancer of Lung
Article | Year |
---|---|
[Cisplatinum compounds].
Topics: Adult; Aged; Antineoplastic Agents; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Ovarian Neoplasms; Prostatic Neoplasms; Testicular Neoplasms | 1993 |
[Development of platinum analogues for the treatment of lung cancer].
Topics: Antineoplastic Agents; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Female; Humans; Lung Neoplasms; Male; Organoplatinum Compounds | 1992 |
2 trial(s) available for dw a 2114r and Cancer of Lung
Article | Year |
---|---|
[Cisplatinum compounds].
Topics: Adult; Aged; Antineoplastic Agents; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Ovarian Neoplasms; Prostatic Neoplasms; Testicular Neoplasms | 1993 |
[Development of platinum analogues for the treatment of lung cancer].
Topics: Antineoplastic Agents; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Female; Humans; Lung Neoplasms; Male; Organoplatinum Compounds | 1992 |
4 other study(ies) available for dw a 2114r and Cancer of Lung
Article | Year |
---|---|
Flow cytometric analyses of the characteristics of tumor cells treated with two platinum compounds: 1,1-cyclobutanedicarboxylato(2-aminomethylpyrrolidine)- platinum(II) and cisplatin.
Topics: Antineoplastic Agents; Bromodeoxyuridine; Carboplatin; Cell Cycle; Cell Division; Cisplatin; DNA, Neoplasm; Drug Interactions; Flow Cytometry; Humans; Ki-67 Antigen; Kinetics; Lung Neoplasms; Mitochondria; Neoplasm Proteins; Nuclear Proteins; Rhodamine 123; Rhodamines; Subcellular Fractions; Time Factors; Tumor Cells, Cultured | 1992 |
[A phase I study on a weekly schedule of DWA2114R].
Topics: Adult; Aged; Antineoplastic Agents; Carboplatin; Drug Administration Schedule; Drug Evaluation; Female; Humans; Infusions, Intravenous; Leukopenia; Lung Neoplasms; Male; Middle Aged; Neutropenia | 1992 |
[Effect of treatment schedule of an antitumor platinum complex, DWA2114R, on the antitumor activity].
Topics: Animals; Antineoplastic Agents; Carboplatin; Colonic Neoplasms; Drug Administration Schedule; Injections; Lung Neoplasms; Male; Mice; Tumor Cells, Cultured | 1992 |
[Comparison of the antitumor activity of newly developed platinum analogs in lung cancer using the colony assay].
Topics: Antineoplastic Agents; Carboplatin; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cell Line; Cisplatin; Humans; In Vitro Techniques; Lung Neoplasms; Organoplatinum Compounds; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1989 |